Gene therapy with human vascular endothelial growth factor in prevention of restenosis after angioplasty
10.3321/j.issn:0258-879X.2001.05.014
- VernacularTitle:hVEGF基因防治血管成形术后再狭窄
- Author:
Shao-Ping CHEN
1
;
Hong GU
;
Yong-Chun WANG
;
Yong-Wen QIN
;
Guo-Yuan ZHANG
Author Information
1. Changhai Hospital Second Military Medical University
- From:
Academic Journal of Second Military Medical University
2001;22(5):443-446
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effect of human vascular endothelial growth factor on restenosis after angioplasty. Methods: A rabbit model of injured carotid artery was established using percutaneous transluminal angioplasty. The pcDNA3/hVEGF165（500 μg,n=12） and pcDNA3 （500 μg,n=12） were separately transfected into injured arterial wall with 30 min incubation. The carotid artery was imaged by arotic angiography at the end of week 2 and week 4. Pathology analysis and Northern blot analysis were performed for harvested injured artery segment. Results: Arotic angiography showed carotid artery diameter narrowness were obviously lessened at week 2 and week 4 in experimental group than that in control group; H-E stains showed lumina narrow ratio were obviously reduced at week 2 and week 4 in experimental group than that in control group［（9.58±1.35）% vs (31.72±1.72)%；(18.09±2.93)% vs (44.05±3.28)%， P<0.01 ］; By Northern blot analysis, the expression of hVEGF165mRNA in experimental group were upregulated than in contol group. Conclusion: pcDNA3/hVEGF165 can be transfected into smooth muscle cell and continue to secret bioactivity protein at least for 4 weeks; it can accelerate reendothelialization and prevent restenosis.
